prezista
janssen-cilag (new zealand) ltd - darunavir ethanolate 325.23mg equivalent to darunavir 300 mg - film coated tablet - 300 mg - active: darunavir ethanolate 325.23mg equivalent to darunavir 300 mg excipient: crospovidone magnesium stearate opadry orange 85f13962 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.
prezista
janssen-cilag (new zealand) ltd - darunavir ethanolate 433.64mg equivalent to darunavir 400 mg - film coated tablet - 400 mg - active: darunavir ethanolate 433.64mg equivalent to darunavir 400 mg excipient: colloidal silicon dioxide crospovidone magnesium stearate opadry orange 85f93377 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.
prezista
janssen-cilag (new zealand) ltd - darunavir ethanolate 650.46mg equivalent to darunavir 600 mg - film coated tablet - 600 mg - active: darunavir ethanolate 650.46mg equivalent to darunavir 600 mg excipient: crospovidone magnesium stearate opadry orange 85f13962 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.
prezista
janssen-cilag (new zealand) ltd - darunavir ethanolate 81.31mg equivalent to darunavir 75 mg - film coated tablet - 75 mg - active: darunavir ethanolate 81.31mg equivalent to darunavir 75 mg excipient: colloidal silicon dioxide crospovidone magnesium stearate opadry white 85f18422 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.
sporanox oral solution
j-c health care ltd - itraconazole - solution - itraconazole 10 mg/ml - itraconazole - itraconazole - sporanox oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis. prevention of fungal infection during neutropenia of immunodeficient patients.
prezista 400 mg
j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 400 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.
prezista 600 mg
j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 600 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.
mycolat 250 mg hard capsules
rowex ltd - mycophenolate mofetil - capsule, hard - 250 milligram(s) - selective immunosuppressants; mycophenolic acid
mycolat 500 mg film-coated tablets
rowex ltd - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid
mycophenolate mofetil 500mg film-coated tablets
wockhardt uk limited - mycophenolate mofetil - film-coated tablet - 500 milligram(s) - selective immunosuppressants; mycophenolic acid